AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading and diverse pipeline in hematology at the 66th American Society of Hematology (ASH) Annual Meeting ...

Application performance monitoring software provider Dynatrace (NYSE:DT) reported Q3 CY2024 results beating Wall Street’s revenue expectations, with sales up 18.9% year on year to $418.1 million.